ENTYVIO (vedolizumab) for injection is used for the treatment of ulcerative colitis, Crohn’s Disease..

DARZALEX is a CD38-directed cytolytic antibody indicated: • in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy • as monotherapy, for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are doublerefractory to a PI and an immunomodulatory agent.

ENTYVIO (vedolizumab) for injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ENTYVIO (vedolizumab) for injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ENTYVIO (vedolizumab) for injection medicine cost price in India.

The order for ENTYVIO (vedolizumab) for injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Vedolizumab (trade name Entyvio) is a monoclonal antibody developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7 (LPAM-1, lymphocyte Peyer's patch adhesion molecule 1, a dimer of Integrin alpha-4 and Integrin beta-7). Blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. It is marketed under the trade name Entyvio.

ENTYVIO (vedolizumab) for injection, for intravenous use Initial U.S. Approval: 2014

Generic Name: vedolizumab

For injection: 300 mg of lyophilized vedolizumab in a single-use 20 mL vial

ENTYVIO (vedolizumab) for injection

Get In Touch

IPN, Delhi can help you access to Entyvio (vedolizumab) in India. Lists the various brand names available for medicines containing vedolizumab by leading Global API Manufacturers. 1. Kynteles (vedolizumab).

ENTYVIO (vedolizumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ENTYVIO (vedolizumab) on prescription and Import License in Patient's Name only.

For overseas patients, ENTYVIO (vedolizumab) can be made available in Send your enquiry to find ENTYVIO (vedolizumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for ENTYVIO (vedolizumab).

Dosage Forms and Strengths: For injection 300 mg of lyophilized vedolizumab in a single-use 20 mL vial. ReadMore

Entyvio® (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn’s Disease Patients in Comparative Effectiveness Real-World Data Analysis.
Dated: Feb 16, 2018 ReadMore

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur